Changzhou Wujin People's Hospital
Changzhou, Jiangsu, 213017, China
NCT Number: NCT05634642
Cardiovascular intervention via distal radial artery (DRA) approach has become more and more extensive. However, the DRA is smaller than conventional radial artery (CRA). Assessing the size of the DRA before vascular intervention is extremely important to select suitable patients. There are still few large-sample studies to evaluate the size of DRA and its influencing factors in the Chinese population.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Changzhou, Jiangsu, 213017, China
In recent years, the clinical application of distal radial artery (DRA) approach in cardiovascular intervention has become more and more extensive. However, compared with CRA, the DRA is smaller, resulting in an increased proportion of patients requiring multiple punctures and a lower success rate of implantation. It has been found that the mismatch between artery sheath and vessel size is one of the independent risk factors for postoperative vascular approach complications. Therefore, assessing the size of the DRA before vascular intervention is extremely important to select suitable patients, improve the success rate of puncture, and reduce the complications associated with the approach There are still few large-sample studies to evaluate the size of DRA and its influencing factors in the Chinese population.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Using ultrasound to measure the diameter of distal radial artery
Time frame: 24 hours before coronary intervention
Measure the diameter of distal radial artery in anatomic snuffbox by ultrasound
Time frame: 24 hours before coronary intervention
Measure the diameter of conventional radial artery by ultrasound
Time frame: 24 hours before coronary intervention
Measure the diameter of ulnar artery by ultrasound
Wujin People's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05006027
Arterial Occlusive Diseases, Arteriosclerosis
Yongin, Gyeonggi-do, South Korea
View Trial DetailsNCT05317533
Catheterization, Complications
Changzhou, Jiangsu, China
View Trial DetailsNCT05253820
Arterial Occlusive Diseases, Arteriosclerosis
Changzhou, Jiangsu, China
View Trial Details